Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	49.9	16.66	53.89	57.47	18.85
Short-Term Investments	0	13.92	26.94	39.36	20
Cash & Cash Equivalents	49.9	30.58	80.82	96.83	38.85
Cash Growth	63.17%	-62.16%	-16.53%	149.21%	107.24%
Other Current Assets	4.49	6.73	7.57	5.76	7.3
Total Current Assets	54.39	37.31	88.39	102.59	46.16
Property, Plant & Equipment	0.45	0.86	1.3	1.71	2.04
Other Long-Term Assets	0	0.2	0.2	0.2	0.2
Total Long-Term Assets	0.45	1.06	1.5	1.91	2.23
Total Assets	54.83	38.36	89.89	104.51	48.39
Accounts Payable	1.74	4.53	9.46	0.64	8.79
Current Debt	0.43	0.48	0.44	0.41	0.36
Other Current Liabilities	69.01	28.41	16.56	20.19	4.95
Total Current Liabilities	71.18	33.42	26.46	21.24	14.1
Long-Term Debt	0.04	0.41	0.89	1.33	1.68
Other Long-Term Liabilities	0.76	0.46	0	0	0
Total Long-Term Liabilities	0.8	0.88	0.89	1.33	1.68
Total Liabilities	71.98	34.3	27.35	22.57	15.78
Total Debt	0.47	0.89	1.33	1.74	2.04
Debt Growth	-47.59%	-33.16%	-23.30%	-14.76%	-
Retained Earnings	-468.59	-348.82	-266.32	-160.73	-66.77
Comprehensive Income	0	0.05	-0.11	-0.11	-0
Shareholders' Equity	-17.15	4.06	62.54	81.94	32.61
Net Cash / Debt	49.43	29.69	79.49	95.09	36.82
Net Cash / Debt Growth	66.50%	-62.65%	-16.41%	158.29%	96.37%
Net Cash Per Share	0.59	0.78	3.11	4.33	2.87
Working Capital	-16.8	3.88	61.93	81.36	32.06
Book Value Per Share	-0.20	0.11	2.44	3.73	2.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).